BioCentury
ARTICLE | Company News

R-Biopharm, Apogenix deal

September 14, 2015 7:00 AM UTC

R-Biopharm and Apogenix partnered to develop companion diagnostics for Apogenix’s APG101. APG101 is in development to treat solid tumors and malignant hematological diseases and is slated to begin a ...